Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.

Hinnen KA, Monninkhof EM, Battermann JJ, van Roermund JG, Frank SJ, van Vulpen M.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):883-8. doi: 10.1016/j.ijrobp.2010.11.049. Epub 2011 Feb 6.

2.

Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.

Mitchell DM, Swindell R, Elliott T, Wylie JP, Taylor CM, Logue JP.

Radiother Oncol. 2008 Jul;88(1):102-7. doi: 10.1016/j.radonc.2008.04.004. Epub 2008 Apr 29.

PMID:
18453022
3.

PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.

Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Mahadevan A, Chehade N, Altman A, Klein EA.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):512-7. Epub 2005 Oct 6.

PMID:
16213667
4.

Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.

Kollmeier MA, Stock RG, Stone N.

Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):645-53.

PMID:
14529768
5.

Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.

Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):664-73.

PMID:
11849788
6.

PSA bounce predicts early success in patients with permanent iodine-125 prostate implant.

Patel C, Elshaikh MA, Angermeier K, Ulchaker J, Klein EA, Chehade N, Wilkinson DA, Reddy CA, Ciezki JP.

Urology. 2004 Jan;63(1):110-3.

PMID:
14751360
7.

Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

Stock RG, Stone NN, Cesaretti JA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):448-53.

PMID:
12738319
8.
9.

Prostate-specific antigen spikes after permanent prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):450-6.

PMID:
12243821
10.

PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.

Crook J, Gillan C, Yeung I, Austen L, McLean M, Lockwood G.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):426-33.

PMID:
17869662
11.

Prostate-specific antigen bounce after high-dose-rate monotherapy for prostate cancer.

Mehta NH, Kamrava M, Wang PC, Steinberg M, Demanes J.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):729-33. doi: 10.1016/j.ijrobp.2013.02.032. Epub 2013 Apr 12.

PMID:
23582852
12.

Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.

Critz FA, Williams WH, Levinson AK, Benton JB, Schnell FJ, Holladay CT, Shrake PD.

J Urol. 2003 Nov;170(5):1864-7.

PMID:
14532794
13.

PSA bounce and biochemical failure after brachytherapy for prostate cancer: a study of 820 patients with a minimum of 3 years of follow-up.

Caloglu M, Ciezki JP, Reddy CA, Angermeier K, Ulchaker J, Chehade N, Altman A, Magi-Galuzzi C, Klein EA.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):735-41. doi: 10.1016/j.ijrobp.2010.02.021. Epub 2010 Jun 18.

PMID:
20646846
14.

Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.

Satoh T, Ishiyama H, Matsumoto K, Tsumura H, Kitano M, Hayakawa K, Ebara S, Nasu Y, Kumon H, Kanazawa S, Miki K, Egawa S, Aoki M, Toya K, Yorozu A, Nagata H, Saito S, Baba S.

BJU Int. 2009 Apr;103(8):1064-8. doi: 10.1111/j.1464-410X.2008.08234.x. Epub 2008 Nov 25.

15.

[PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure].

Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, Rosenwald JC, Cosset JM.

Cancer Radiother. 2007 May;11(3):105-10. Epub 2006 Dec 8. French.

PMID:
17158082
16.
18.

A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer.

Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg D, Pollack A.

Am J Clin Oncol. 2006 Oct;29(5):458-62.

PMID:
17023779
19.

PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.

Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, Rosenwald JC, Cosset JM.

Brachytherapy. 2006 Apr-Jun;5(2):122-6.

PMID:
16644467
20.

Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence.

Mazeron R, Bajard A, Montbarbon X, Gassa F, Malet C, Rocher F, Clippe S, Bringeon G, Desmettre O, Pommier P.

Radiat Oncol. 2012 Mar 26;7:46. doi: 10.1186/1748-717X-7-46.

Supplemental Content

Support Center